The latency pattern of Epstein–Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas (original) (raw)

• Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J and Favrot MC (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82: 2169–2174
  CAS Google Scholar
• Brooks L, Yao QY, Rickinson AB and Young LS (1992) Epstein–Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66: 2689–2697
  CAS Google Scholar
• Chan JKC, Sin VC, Wong KF, Ng CS, Tsang YW, Chan CH, Cheung MMMC and Lau WH (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of uncommon aggressive neoplasm. Blood 89: 4501–4513
  CAS Google Scholar
• Cohen JL and Lekstrom K (1999) Epstein–Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J Virol 73: 7627–7632
  CAS Google Scholar
• Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB and Young LS (1993) Epstein–Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177: 339–349
  Article CAS Google Scholar
• Fahraeus R, Rumo L, Rhim JS and Klein G (1990) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein–Barr virus. Nature 345: 447–449
  Article CAS Google Scholar
• Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ and Pallesen G (1993) Epstein–Barr virus-latent gene expression and tumour cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143: 1072–1085
  CAS Google Scholar
• Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F and Osato T (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335: 128–130.
  Article CAS Google Scholar
• Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink K, Vardiman J, Lister TA and Bloomfield CD (1999) World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting – Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835–3849
  Article CAS Google Scholar
• Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A (1991) Induction of bcl-2 expression by Epstein–Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107–1115
  Article CAS Google Scholar
• Henderson S, Huen D, Rowe M, Dawson C, Johnson G and Rickinson A (1993) Epstein–Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Acad Sci USA 90: 8479–8483
  Article CAS Google Scholar
• Hsu DH, Malefyt RDW, Fiorentino DF, Dang MN, Vieira P, deVries J, Spits H, Mosmann TR and Moore KW (1990) Expression of Interleukin-10 activity by Epstein–Barr virus protein BCRF1. Science 250: 830–832
  Article CAS Google Scholar
• Hudson GS, Bankier SC, Satchwell and Barrell BG (1985) The short unique region of the B95.8 Epstein–Barr virus genome. Virology 147: 81–85
  Article CAS Google Scholar
• Iwatsuki K, Ohtsuka M, Harada H, Han G and Kaneko F (1997) Clinicopathologic manifestations of Epstein–Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 133: 1081–1086
  Article CAS Google Scholar
• Jaffe ES, Costa J, Fauci AS, Cossman J and Tsokos M (1983) Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75: 741–749
  Article CAS Google Scholar
• Jaffe ES, Chan JKC, Su IJ, Frizzera G, Mori S, Feller AC and Ho FCS (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 20: 103–111
  Article CAS Google Scholar
• Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH and Rickinson AB (1992) Three transcriptionally distinct forms of Epstein–Barr virus latency in somatic cells hybrids: cell phenotype dependence of viral promotoer usage. Virology 187: 189–201
  Article CAS Google Scholar
• Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG and Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of Epstein–Barr virus nuclear antigen-1. Nature 375: 685–688
  Article CAS Google Scholar
• Miller G (1990) The switch between latency and replication of Epstein–Barr virus. J Infect Dis 161: 833–844
  Article CAS Google Scholar
• Miyazaki I, Cheung RK and Dosch HM (1993) Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein–Barr virus. J Exp Med 178: 439–447
  Article CAS Google Scholar
• Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA and Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein–Barr virus gene BCRF1. Science 248: 1230–1234
  Article CAS Google Scholar
• Ohtsuka M, Iwatsuki K, Kaneko R, Akiba H, Kikuchi S, Harada H and Kaneko F (1999) Epstein–Barr virus-associated lymphoid hyperplasia of the eyelid characterized by intramuscular infiltration. Br J Dermatol 140: 358–359
  Article CAS Google Scholar
• Oudejans JJ, Jiwa M, van den Brule AJC, Grasser FA, Horstman A, Vos W, Kluin PM, van der Valk P, Walboomers JMM and Meijer CJLM (1995a) Detection of heterogeneous Epstein–Barr virus gene expression patterns within individual post-transplanation lymphoproliferative disorders. Am J Pathol 147: 923–933
  CAS Google Scholar
• Oudejans JJ, van den Brule AJC, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JMM and Meijer CJLM (1995b) BHRF1, the Epstein–Barr virus (EBV) homologue of the Bcl-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 86: 1893–1902
  CAS Google Scholar
• Raab-Traub N and Flynn K (1986) The structure of the termini of the Epstein–Barr virus as a marker of clonal cellular proliferation. Cell 47: 883–889
  Article CAS Google Scholar
• Rickinson AB, Young LS and Rowe M (1987) Influence of the Epstein–Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. J Virol 61: 1310–1317
  CAS Google Scholar
• Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H and Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein–Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743–2751
  Article CAS Google Scholar
• Sample J, Brooks L, Sample C, Young LS, Rowe M, Gregory C, Rickinson AB and Kieff E (1991) Restricted Epstein–Barr virus protein expression in Burkitt lymphoma is due to a different Epstein–Barr nuclear antigen 1 transcriptional initiation. Proc Natl Acad Sci USA 88: 6343–6347
  Article CAS Google Scholar
• Schaefer BC, Woisetschlaeger M, Strominger JL and Speck SH (1991) Exclusive expression of Epstein–Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci USA 88: 6550–6554
  Article CAS Google Scholar
• Su IJ and Hsieh HC (1992) Clinicopathological spectrum of Epstein–Barr virus-associated T cell malignancies. Leukemia Lymphoma 7: 47–53
  Article CAS Google Scholar
• Su IJ, Hsieh HC, Lin KH, Kao WCL, Chen CL, Cheng AL, Kadin ME and Chen JY (1991) Aggressive peripheral T-cell lymphoma containing Epstein–Barr virus DNA: A clinical, pathologic and molecular analysis. Blood 77: 799–808
  CAS Google Scholar
• Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K and Osato T (1996) Transcription analysis of Epstein–Barr virus gene expression in EBV positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74: 625–631
  Article CAS Google Scholar
• Tao Q, Robertson KD, Manns A, Hildesheim A and Ambinder RF (1998) Epstein–Barr virus in endemic Burkitt's lymphoma: molecular analysis of primary tumour tissue. Blood 91: 1373–1381
  CAS Google Scholar
• Wang D, Liebowitz D and Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831–840
  Article CAS Google Scholar
• Xu ZG, Iwatsuki K, Ohtsuka M, Oyama N, Matsui T and Kaneko F (2000) Polymorphism analysis of Epstein–Barr virus isolates from patients with cutaneous NK/T-cell lymphoproliferative disorders: a possible relation to the endemic occurrence of these diseases in Japan. J Med Virol 62: 239–246
  Article CAS Google Scholar
• Young LS, Alfieri C, Hennessy K, Evans H, Ohara C, Anderson KC, Ritz J, Shapiro RS, Rockinson A and Kieff E (1989) Expression of Epstein–Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321: 1080–1085
  Article CAS Google Scholar
• Zeidler R, Eissner G, Meissner P, Uebel S, Tamp R, Lazis S and Hammerschmidt W (1997) Downregulation of TAP1 in B lymphocytes by cellular and Epstein–Barr virus-encoded interleukin-10. Blood 90: 2390–2397
  CAS Google Scholar